Finally, data exists in the literature describing the efficacy of the 5-HT2A antagonist TZD to attenuating pain perception in rats suffering from chronic constriction (Okuda et al., 2003) and in humans suffering from diabetic neuropathy (Wilson, 1999). The gene discussed is HTR2A; the disease is diabetic neuropathy.